Within the framework of the TOMBOLA randomized controlled trial of alternative managements , @ women aged @ to @ years with a single routine cytology test showing borderline nuclear abnormalities ( BNA ; broadly equivalent to atypical squamous cells of undetermined significance ) were assigned to follow-up by repeat cytology in primary care ( the first test was due @ months after the initial BNA result ) .